Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Rose

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Hospital Medicine (London, England : 1998)|October 26, 2000
Anticoagulant therapy and referral form. Haemostasis and Thrombosis Task Force of the British Committee for Standards in HaematologyP E Rose
BMJ (Clinical Research Ed.)|May 16, 2000
Using anticoagulation or aspirin to prevent stroke. Patients should be assessed for risk factors before deciding on prophylaxisP E Rose
Journal of Clinical Pathology|January 1, 1996
Audit of anticoagulant therapyP E Rose
Journal of Microscopy|February 1, 1980
Improved tables for the evaluation of sphere size distributions including the effect of section thicknessP E Rose
Lancet (London, England)|May 28, 1988
Yersinia and haemolytic uraemic syndromeJ Kavi, P E Rose
Blood Reviews|July 14, 1998
New approaches to the delivery of anticoagulant servicesP E Rose, D Fitzmaurice
BMJ (Clinical Research Ed.)|February 3, 1990
Computer control of anticoagulant doseP E Rose, M Gilbert
Journal of Clinical Pathology|July 1, 1986
Classification of haemolytic uraemic syndromeR P Cooke, P E Rose
Medical Laboratory Sciences|October 1, 1983
Serological reactions using low ionic strength saline (LISS) in patients with rheumatoid arthritisP E Rose, G R Struthers
Blood Reviews|June 1, 1989
Haematology of the haemolytic uraemic syndromeP E Rose, A J Clark
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Hospital Medicine (London, England : 1998)|October 26, 2000
Anticoagulant therapy and referral form. Haemostasis and Thrombosis Task Force of the British Committee for Standards in HaematologyP E Rose
BMJ (Clinical Research Ed.)|May 16, 2000
Using anticoagulation or aspirin to prevent stroke. Patients should be assessed for risk factors before deciding on prophylaxisP E Rose
Journal of Clinical Pathology|January 1, 1996
Audit of anticoagulant therapyP E Rose
Journal of Microscopy|February 1, 1980
Improved tables for the evaluation of sphere size distributions including the effect of section thicknessP E Rose
Lancet (London, England)|May 28, 1988
Yersinia and haemolytic uraemic syndromeJ Kavi, P E Rose
Blood Reviews|July 14, 1998
New approaches to the delivery of anticoagulant servicesP E Rose, D Fitzmaurice
BMJ (Clinical Research Ed.)|February 3, 1990
Computer control of anticoagulant doseP E Rose, M Gilbert
Journal of Clinical Pathology|July 1, 1986
Classification of haemolytic uraemic syndromeR P Cooke, P E Rose
Medical Laboratory Sciences|October 1, 1983
Serological reactions using low ionic strength saline (LISS) in patients with rheumatoid arthritisP E Rose, G R Struthers
Blood Reviews|June 1, 1989
Haematology of the haemolytic uraemic syndromeP E Rose, A J Clark
Pageof 7